Page 40 - วารสารการแพทย์แผนไทย ปีที่ 21 ฉบับที่ 2
P. 40

256 วารสารการแพทย์แผนไทยและการแพทย์ ทางเลือก      ปีที่ 21  ฉบับที่ 2  พฤษภาคม-สิงหาคม 2566




           Table 2  Comparative results of sensory symptoms and pain between the SHT remedy and placebo groups

               Score McGill           SHT remedy        Placebo        Mean difference   p - value
                                       (n = 31)         (n = 31)         (95%CI)
                                      Mean ± SD        Mean ± SD

            Sensory score
              Day 0                  6.58 ± 2.17      5.42 ± 1.80     1.16 (0.15, 2.18)   0.026*
                   a
              Day 14                 4.52 ± 1.96      5.19 ± 1.74    -0.68 (-1.62, 0.27)   0.156
              Day 28                 3.29 ± 1.79      4.87 ± 1.89   -1.58 (-2.52, -0.64)  0.001*
                   a
                             b
              Change score analysis    -1.62 (-1.83, -1.4)  -0.30 (-0.52, -0.09)  -1.23 (-1.69, -0.77)  < 0.001*
            Affective score
              Day 0                  3.65 ± 1.68      3.61 ± 1.50    0.03 (-0.78, 0.84)   0.937
              Day 14                 2.65 ± 1.74      2.94 ± 1.53    -0.29 (-1.12, 0.54)   0.488
                   a
                   a
              Day 28                 1.81 ± 1.56      2.52 ± 1.41    -0.71 (-1.47, 0.05)   0.065
                             b
              Change score analysis    -0.92 (-1.08, -0.75) -0.55 (-0.72, -0.38)  -0.35 (-0.66, -0.05)  0.024*
            Total score
              Day 0                  10.23 ± 3.20     9.03 ± 1.96    1.19 (-0.16, 2.54)   0.082
              Day 14                 7.16 ± 3.31      8.13 ± 2.13    -0.97 (-2.32, 0.39)   0.158
                   a
              Day 28                 5.10 ± 2.84      7.39 ± 2.42   -2.29 (-3.63, -0.95)  0.001*
                   a
              Change score analysis    -2.54 (-2.82, -2.27) -0.84 (-1.12, -0.56)  -1.66 (-2.23, -1.09)  < 0.001*
                             b
            Total count
              Day 0                  5.71 ± 1.76      5.06 ± 1.41    0.65 (-0.16, 1.46)   0.116
                   a
              Day 14                 5.52 ± 1.65      4.97 ± 1.33    0.55 (-0.21, 1.31)   0.155
              Day 28                 4.48 ± 2.03      4.84 ± 1.44    -0.36 (-1.25, 0.54)   0.431
                   a
              Change score analysis    -0.57 (-0.7, -0.43)  -0.16 (-0.3, -0.02)  -0.33 (-0.54, -0.12)  0.002*
                             b
            Present pain index (PPI)
              Day 0                  2.42 ± 0.50      2.23 ± 0.48    0.10 (-0.15, 0.35)   0.439
                   a
              Day 14                 2.13 ± 0.43      2.26 ± 0.45    -0.13 (-0.35, 0.09)   0.249
                   a
              Day 28                 1.94 ± 0.44      2.16 ± 0.45    -0.23 (-0.45, 0.00)   0.052
              Change score analysis    -0.24 (-0.3, -0.18)  -0.08(-0.14, -0.02)  -0.15 (-0.26, -0.04)  0.005*
                             b
            Visual analog scale (VAS)
              Day 0                 72.58 ± 10.41     67.87 ± 8.94   4.71 (-0.22, 9.64)   0.061
              Day 14                 58.10 ± 8.86    62.52 ± 11.30   -4.42 (-9.58, 0.74)   0.092
                   a
              Day 28                 44.16 ± 11.8    55.68 ± 11.99   -11.52 (-17.56, -5.47)  < 0.001*
                   a
              Change score analysis   -13.92 (-15.61, -12.23) -6.39 (-8.08, -4.7)  -6.72 (-10.06, -3.38)  < 0.001*
                             b
            a  Independent t-test   generalized estimating equation (GEE)   Statistical significance p < 0.05
                                                   *
                          b
   35   36   37   38   39   40   41   42   43   44   45